Top Markets
#1 Glidr Glidr +51.75%
#2 Akedo Akedo +50.81%
#3 DOVU DOVU +50.51%
#4 Cross Cross +49.17%
#5 Black Phoenix Black Phoenix +34.33%
#6 Velvet Velvet +32.01%
#7 OVERTAKE OVERTAKE +22.01%
#8 Cap Cap +17.55%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.28%
#10 Movement Movement +13.76%
Coin of the day
Glidr Glidr
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
GABY Inc. GABY Inc.

GABY Inc.

GABY
Pozycja w akcjach #38692
GABY Inc., through its subsidiaries, is engaged in the manufacturing,... GABY Inc., through its subsidiaries, is engaged in the manufacturing, promotion, distribution, and retail sale of cannabis-related consumer packaged goods across the United States. The firm's offerings span a broad array of cannabis products, such as packaged flower, concentrated extracts, pre-rolled items, edibles, topical applications, tinctures, and other goods infused with or derived from cannabis or hemp. These cannabis products are marketed under the brand names Mankind, Kind Republic, Lulu's, 2Rise, and Dank Space. Established in 2003, the company was formerly known as Gabriella's Kitchen Inc. before rebranding as GABY Inc. in September 2019. GABY Inc. maintains its headquarters in Calgary, Canada.
Cena akcji
$0.00372038
Ostatnia synchronizacja: 2023-08-11
Kapitalizacja rynkowa
$849.73K
Zmiana (1 dzień)
0.04%
Zmiana (1 rok)
0.00%
Kraj
CA
Handel GABY Inc. (GABY)

Kategoria

Healthcare
Historia ceny akcji dla GABY Inc. (GABY)
Najwyższa cena zamknięcia: $0.00 dnia 2023-08-01

Najniższa cena zamknięcia: $0.29 dnia 2018-09-01
Historia cen akcji firmy GABY Inc. od 2018 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2023 -3.19%
2022 -82.36%
2021 -53.66%
2020 -36.58%
2019 -71.91%
2018 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $58.60 60.55%
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 $49.19 73.40%
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 $185.04 42.71%
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 $62.27 4.40%
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $114.60 59.17%
US